| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16,503 |
8,631 |
$151K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
24,864 |
11,144 |
$101K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,761 |
1,299 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
731 |
442 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
862 |
458 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
819 |
578 |
$6K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
270 |
178 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
425 |
289 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
180 |
105 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
27 |
15 |
$151.89 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
60 |
50 |
$0.00 |